Effect of troglitazone on urinary excretion of 6β-hydroxycortisol

Journal of Clinical Pharmacology

Volumn 38, Issue 9, 1998, Pages 815-818

  Koup, Jeffrey R ^a   Anderson, Gail D ^b   Loi, Cho Ming ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; CARBAMAZEPINE; CYTOCHROME P450; DIGOXIN; ETHINYLESTRADIOL; HYDROCORTISONE; INSULIN; LANSOPRAZOLE; MESTRANOL PLUS NORETHISTERONE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN; TERFENADINE; TROGLITAZONE; VIGABATRIN;

AEROBIC METABOLISM; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG CROSS REACTIVITY; DRUG METABOLISM; ENZYME INDUCTION; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE URINE LEVEL; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; URINARY EXCRETION;

ARYL HYDROCARBON HYDROXYLASES; CARDIOTONIC AGENTS; CHROMANS; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DIGOXIN; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ENZYME INDUCTION; HUMANS; HYDROCORTISONE; HYPOGLYCEMIC AGENTS; OXIDOREDUCTASES, N-DEMETHYLATING; SENSITIVITY AND SPECIFICITY; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031655412     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Loi CM, Stern R, Vassos AB, Koup JR, Sedman A: Effect of troglitazone on terfenadine pharmacokinetics (abstract). Clin Pharmacol Ther 1998;63:228.
2. Ling K-HJ, Leeson GA, Burmaster SD, Hook RH, Reith MK, Cheng LK: Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes. Drug Metab Dispos 1995; 23:631-636.
3. Guengerich FP: Oxidation of 17α-ethinylestradiol by human liver cytochrome P-450. Mol Pharmacol 1988;33:500-508.
4. Apseloff G, Hilligoss DM, Gardner MJ, Henry EB, Inskeep PB, Gerber N, Lazar JD: Induction of fluconazole metabolism by rifampin: in vivo study in humans, J Clin Pharmacol 1991;31:358-361.
5. Bartoli A, Gatti G, Cipolla G, Barzaghi N, Veliz G, Fattore C, et al: A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers. Epilepsia 1997;38:702-707.
6. Bienvenu T, Rey E, Pons G, d'Athis P, Olive G: A simple non-invasive procedure for the investigation of cytochrome P450IIIA dependent enzymes in humans. Int J Clin Pharmacol Ther Toxicol 1991;29:441-445.
7. Desager JP, Dumont E, Harvengt C: The urinary 6β-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase. Pharmacol Ther 1987;33:197-199.
8. Fleishaker JC, Pearson LK, Peters GR: Phenytoin causes a rapid increases in 6β-hydroxycortisol urinary excretion in humans a putative measure of CYP3A induction. J Pharm Sci 1995;84:292-294.
9. Ged C, Rouillon JM, Picard L, Combalbert J, Bressot N, Bories P, et al: The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol 1989;28:373-387.
10. Kuhnz W, Lofberg B: Urinary excretion of 6β-hydroxycortisol in women during treatment with different oral contraceptive formulations. J Steroid Biochem Mol Biol 1995;55:129-133.
11. Larkin JG, McKee PJ, Forrest G, Beastall GH, Park BK, Lowrie JI, et al: Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects. Br J Clin Pharmacol 1991;31:65-71.
12. Moreland TA, Park BK, Rylance GW: Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6β-hydroxycortisol excretion and plasma γ-glutamyltranspeptidase activity. Br J Clin Pharmacol 1982;14: 861-865.
13. Ohnhaus EE, Park BK: Measurement of urinary 6β-hydroxyCortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampin. Eur J Clin Pharmacol 1979;15:139-145.
14. Ohnhaus EE, Gerber-Taras E, Park BK: Enzyme inducing drug combinations and their effects on liver microsomal enzyme activity in man. Eur J Clin Pharmacol 1983;24:247-250.
15. Perucca E, Grimaldi R, Frigo GM, Sardi A, Moenig H, Ohnhaus EE: Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects. Eur J Clin Pharmacol 1988;34:595-599.
16. Roots I, Holbe R, Hovermann W, Nigam S, Heinemeyer G, Hildebrandt AG: Quantitative determination by HPLC of urinary 6β-hydroxycortisol: an indicator of enzyme induction by rifampicin and antiepileptic drugs. Eur J Clin Pharmacol 1979;16:63-71.
17. Rost KL, Borsicke H, Heinemeyer G, Roots I: Specific and dose-dependent enzyme induction by omperazole in human beings. Hepatology 1994;20:1204-1212.
18. Rost KL, Mansmann U, Roots I: Urinary 6β-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment. Int J Clin Pharmcol Ther 1997;35:14-18.
19. Saenger P: 6-beta-hydroxycortisol in random urine samples as an indicator of enzyme induction. Clin Pharmacol Ther 1983;34: 818-821.
20. Watkins PB: Noninvasive tests of CYP3A enzymes. Pharmacogenetics 1994;4:171-184.
21. Loi CM, Knowlton P, Stern R, Randinitis EJ, Vassos AB, Koup JR, Sedman AJ: Effect of troglitazone on steady-state pharmacokinetics of digoxin. J Clin Pharmacol 1998;38:178-183.